PRME
Prime Medicine Inc
$3.60
0.03 (0.81%) Today
0.09 (2.44%) After-hours
— up— down
Market Cap
$672M+49.4%
Revenue (TTM)
$4.12M+4.9%
Net Income (TTM)
$-227,490,890
$-227,490,890EPS (TTM)
-1.26
-1.26Shares Out
180.62M
180.62MOpen
$3.76
$3.76Previous Close
$3.72
$3.72Day Range
$3.62 – $3.79
$3.62 – $3.7952-Week Range
$2.28 – $6.94
$2.28 – $6.94Beta
2.23
2.23Volume
2.65M
2.65MAvg Volume
2.68M
2.68MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout PRME
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.